Download Citation
Article Source:
An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity
Norheim G,
Sanders H,
Mellesdal JW,
Sundfør I,
Chan H,
et al.
(2015)
An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity.
PLOS ONE 10(9): e0134353.
https://doi.org/10.1371/journal.pone.0134353